best glp-1 agonists for weight loss Which Agonist is Loss? GLP-1 Drugs for Weight Loss:

Lifestyle modifications and medications serve as adjuncts, not primary therapy

Cell Commun Signal

Cannon CP, Pratley R, Dagogo-Jack S et al (2020) Cardiovascular outcomes with ertugliflozin in type 2 diabetes

IQVIA blog, October 2024: Wang et al, Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US

The effect of vitamin D supplementation on glycemic control and cardiovascular risk factors in type 2 diabetes: an updated systematic review and meta-analysis of clinical trials

Endocrine News senior editor Derek Bagley looks at this phenomenon in The Agonists and the Ecstasy where he talks to endocrinologists about the popularity of these drugs,, as well as some of the inequities many patients face in obtaining treatment